Mechanistic adaptability of cancer cells strongly affects anti-migratory drug efficacy

Wei Sun1, Chwee Teck Lim2, Nicholas Agung Kurniawan3

  • 1NUS Graduate School for Integrative Sciences and Engineering, Singapore 117456, Republic of Singapore.

Insights

Drug effectiveness against cancer metastasis varies with the extracellular matrix (ECM) environment. Targeting cytoskeletal contractility works in sparse gels, while inhibiting proteolysis is key in dense gels for anti-metastasis drug screening.

Area of Science:

  • Biomedical Engineering
  • Cancer Biology
  • Materials Science

Background:

  • Cancer metastasis is a major cause of cancer mortality.
  • Drug screening for anti-metastasis therapies often uses 3D hydrogel models mimicking the extracellular matrix (ECM).
  • Understanding how cancer cells invade through the ECM is crucial for developing effective treatments.

Purpose of the Study:

  • To develop a mechanically tuneable collagen hydrogel model to simulate cancer cell invasion into heterogeneous tumor stroma.
  • To investigate the impact of ECM biophysical properties on cancer cell migration and drug efficacy.
  • To assess how different anti-metastasis drugs perform under varying matrix conditions.

Main Methods:

  • Fabrication of a mechanically tuneable collagen hydrogel system.
  • Monitoring 3D invasion of highly malignant breast cancer cells (MDA-MB-231).
  • Conducting migration assays with drugs targeting cell migration mechanisms across diverse ECMs with varied biophysical properties.

Main Results:

  • Drug effects on cancer cell migration were highly dependent on matrix mechanics and microarchitecture.
  • Cytoskeletal contractility inhibitors reduced migration in sparse gels.
  • Proteolysis inhibitors were effective in retarding migration in dense gels.
  • Cancer cells demonstrated adaptability in switching invasion mechanisms based on ECM conditions.

Conclusions:

  • The efficacy of anti-metastasis drugs is significantly influenced by the biophysical properties of the tumor microenvironment.
  • Cancer cells exhibit plasticity in their invasion strategies, adapting to different ECM conditions.
  • Incorporating ECM biophysical properties into anti-metastasis drug screening is essential for developing effective therapies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K